Anemia, Iron-Deficiency Clinical Trial
Official title:
A Randomized, Double-blind Comparative Study Comparing Ferric Carboxymaltose (Ferinject) and Iron Isomaltoside 1000 (Monofer) for Iron Substitution in Iron-deficiency Anemia
The purpose of this study is to determine to what extend a treatment with the iron compounds Iron Isomaltoside 1000 or Ferric Carboxymaltose is leading to hypophosphatemia and to study the potential clinical impact of hypophosphatemia.
Recent studies suggested that intravenous iron preparations for anemia treatment may have adverse effects on phosphorus regulation, as they may induce an increase in the phosphaturic hormone Fibroblast Growth Factor-23 (FGF-23) and a subsequent fall in plasma phosphorus levels. So far it is unknown if these effects are class- or substance-specific. This study will address the question whether among female participants with iron deficiency anemia the application of ferric-(III)-derisomaltose and ferric carboxymaltose will cause episodes of hypophosphatemia to same extend. The investigators will additionally compare the effects of the two iron preparations on other parameters of calcium-phosphate metabolism, and decipher potential consequences of hypophosphatemia by analysing cardiac function, immunological parameters and quality of life. In order to investigate these outcomes, 60 women with iron deficient anemia will be randomised to receive either ferric-(III)-derisomaltose or ferric carboxymaltose. The monocentric study will be conducted at Saarland University Medical Center. For each participating woman, the study comprises five visits to the study center during a period of five weeks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03516734 -
Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh
|
N/A | |
| Completed |
NCT02570854 -
A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients
|
Phase 1 | |
| Completed |
NCT02887963 -
Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia in Chinese Pregnant Women
|
N/A | |
| Completed |
NCT00534144 -
Comparison Between Effects of Two Iron Preparations on Protein in the Urine
|
Phase 1 | |
| Completed |
NCT00224081 -
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
|
Phase 4 | |
| Recruiting |
NCT02999217 -
Intravenous Iron for Correction of Anaemia After Colorectal Surgery
|
Phase 4 | |
| Recruiting |
NCT04351607 -
Preoperative Supplementation of Sucrosomal Iron as Hematopoietic Support.
|
N/A | |
| Completed |
NCT04163406 -
The Effect of Human Milk Oligosaccharides and Galacto-oligosaccharides on Iron Absorption in Kenyan Infants
|
N/A | |
| Completed |
NCT02365103 -
Tea Consumption and Iron Bioavailability in Women Using a Stable Isotope
|
N/A | |
| Completed |
NCT00536666 -
A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients
|
Phase 3 | |
| Completed |
NCT02310607 -
Non-invasive Optical Detection of Iron Deficiency
|
N/A | |
| Completed |
NCT01755455 -
Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis
|
N/A | |
| Terminated |
NCT00929409 -
Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
|
Phase 2/Phase 3 | |
| Completed |
NCT00354692 -
Effect of Two Iron Preparations on Protein in the Urine
|
Phase 4 | |
| Recruiting |
NCT05628896 -
Efficacy of a Preoperative Anaemia Clinic in Patients Undergoing Elective Abdominal Surgery
|
||
| Completed |
NCT02892461 -
Effect of Umbilical Cord Milking on Iron Related Health Outcomes for Cesarean-Delivered Infants
|
N/A | |
| Not yet recruiting |
NCT01840384 -
Efficacy Study of Multiple Micro Nutrients Supplementation
|
N/A | |
| Recruiting |
NCT00125996 -
Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT04975074 -
Iron Deficiency Anemia in Twin Pregnancies
|
Phase 4 | |
| Completed |
NCT03565354 -
Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical Patients
|
Phase 3 |